Cite
Rethinking Composite End Points in Clinical Trials.
MLA
Stolker, Joshua M., et al. “Rethinking Composite End Points in Clinical Trials.” Circulation, vol. 130, no. 15, Oct. 2014, pp. 1254–61. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.113.006588.
APA
Stolker, J. M., Spertus, J. A., Cohen, D. J., Jones, P. G., Jain, K. K., Bamberger, E., Lonergan, B. B., & Chan, P. S. (2014). Rethinking Composite End Points in Clinical Trials. Circulation, 130(15), 1254–1261. https://doi.org/10.1161/CIRCULATIONAHA.113.006588
Chicago
Stolker, Joshua M., John A. Spertus, David J. Cohen, Philip G. Jones, Kaushik K. Jain, Emily Bamberger, Brady B. Lonergan, and Paul S. Chan. 2014. “Rethinking Composite End Points in Clinical Trials.” Circulation 130 (15): 1254–61. doi:10.1161/CIRCULATIONAHA.113.006588.